Treatments : Shots - Health News Here you can find out how the practice of medicine is changing. We pull together the latest research on medical tests, drugs and other therapies.
Shots - Health News

Shots

Health News From NPR

Treatments

Pfizer plans to file within days with the Food and Drug Administration to allow emergency use of its COVID-19 vaccine. Bebeto Matthews/AP hide caption

toggle caption
Bebeto Matthews/AP

Pfizer To Seek FDA OK For COVID-19 Vaccine 'Within Days'

  • Download
  • <iframe src="https://www.npr.org/player/embed/936060122/936136602" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

In an aerial view from a drone, cars line up at Dodger Stadium for COVID-19 testing in Los Angeles, California. David McNew/Getty Images hide caption

toggle caption
David McNew/Getty Images

A Rush On Coronavirus Testing Strains Laboratories, Drives Supply Shortages

  • <iframe src="https://www.npr.org/player/embed/935809271/935812521" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The Pfizer COVID-19 vaccine needs to be stored at minus 70 Celsius. Health care providers will need to store it either in dry ice for shorter stints or in specialized freezers. Leon Neal/Getty Images hide caption

toggle caption
Leon Neal/Getty Images

Why Does Pfizer's COVID-19 Vaccine Need To Be Kept Colder Than Antarctica?

  • Download
  • <iframe src="https://www.npr.org/player/embed/935563377/935655911" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Clinical data for Moderna's COVID-19 vaccine showed it was nearly 95% effective in preventing disease, according to an interim analysis described in a company release Monday. Maddie Meyer/Getty Images hide caption

toggle caption
Maddie Meyer/Getty Images

Moderna's COVID-19 Vaccine Shines In Clinical Trial

  • Download
  • <iframe src="https://www.npr.org/player/embed/935239294/935318874" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Novavax released its federal contract to develop and supply a COVID-19 vaccine. The agreement reveals terms that weren't previously known. Bloomberg via Getty Images hide caption

toggle caption
Bloomberg via Getty Images

"One of the greatest gifts is to feel alive while you are alive," Katherine Standefer says. She writes about her experiences living with an implantable cardiac defibrillator in Lightning Flowers. Luke Parsons/Hachette Book Group hide caption

toggle caption
Luke Parsons/Hachette Book Group

Author Details 'Living With Death' In Her 20s And Scrambling For Life-Saving Care

  • Download
  • <iframe src="https://www.npr.org/player/embed/933384696/933488183" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Sean McMinn/NPR

COVID-19 Hospitalizations Hit Record Highs. Where Are Hospitals Reaching Capacity?

  • Download
  • <iframe src="https://www.npr.org/player/embed/933253317/933343142" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Pfizer said a clinical trial of its experimental COVID-19 vaccine found it to be more than 90% effective. Mark Lennihan/AP hide caption

toggle caption
Mark Lennihan/AP

Pfizer Says Experimental COVID-19 Vaccine Is More Than 90% Effective

  • Download
  • <iframe src="https://www.npr.org/player/embed/933006651/933225069" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The hallucinogenic chemical psilocybin produced in some mushrooms helped people with major depression in a study that also included supportive psychotherapy. Jahi Chikwendiu/The Washington Post via Getty Images hide caption

toggle caption
Jahi Chikwendiu/The Washington Post via Getty Images

Rigorous Study Backs A Psychedelic Treatment For Major Depression

  • Download
  • <iframe src="https://www.npr.org/player/embed/931377532/931436050" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An Eli Lilly researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. David Morrison/AP hide caption

toggle caption
David Morrison/AP

Government Signs Deal For COVID-19 Treatments From Eli Lilly

  • Download
  • <iframe src="https://www.npr.org/player/embed/928841997/933343154" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A heavily redacted supply contract between the federal government and vaccine developer Moderna, headquartered in Cambridge, Mass., was released Friday. Joseph Prezioso/AFP via Getty Images hide caption

toggle caption
Joseph Prezioso/AFP via Getty Images

Eli Lilly researchers prepare cells to produce possible COVID-19 antibodies in a laboratory in Indianapolis. The drugmaker has asked the U.S. government to allow emergency use of its experimental antibody therapy. David Morrison/AP hide caption

toggle caption
David Morrison/AP

How Will The Limited Supply Of Antibody Drugs For COVID-19 Be Allocated?

  • Download
  • <iframe src="https://www.npr.org/player/embed/926376342/926376531" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

COVID-19 mortality rates are going down, according to studies of two large hospital systems, partly thanks to improvements in treatment. Here, clinicians care for a patient in July at an El Centro, Calif., hospital. Mario Tama/Getty Images hide caption

toggle caption
Mario Tama/Getty Images

Studies Point To Big Drop In COVID-19 Death Rates

  • Download
  • <iframe src="https://www.npr.org/player/embed/925441975/925895776" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Recruiting patients for medical studies has been challenging during the pandemic, especially older people who are more vulnerable to COVID-19. Getty Images hide caption

toggle caption
Getty Images

A Big Alzheimer's Drug Study Is Proceeding Cautiously Despite The Pandemic

  • Download
  • <iframe src="https://www.npr.org/player/embed/925493843/925501127" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tobacco plants are being used in the development of COVID-19 vaccines. One is already being tested in humans. Rehman Asad/Barcroft Media via Getty Images hide caption

toggle caption
Rehman Asad/Barcroft Media via Getty Images

Tobacco Plants Contribute Key Ingredient For COVID-19 Vaccine

  • <iframe src="https://www.npr.org/player/embed/923210562/925442663" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The nasal spray version of the flu vaccine contains live but weakened form of the virus. Researchers think there's a good chance this could help boost the body's immunity and improve its ability to fight off pathogens such as the coronavirus. Tim Sloan/AFP via Getty Images hide caption

toggle caption
Tim Sloan/AFP via Getty Images

A new wave of rapid coronavirus tests has entered the market with the potential to greatly expand screening for the virus. Spencer Platt/Getty Images hide caption

toggle caption
Spencer Platt/Getty Images

Can The U.S. Use Its Growing Supply Of Rapid Tests To Stop The Virus?

  • Download
  • <iframe src="https://www.npr.org/player/embed/915793729/919006741" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

African Americans and other underrepresented minorities make up only about 5% of the people in genetics research studies. janiecbros/Getty Images hide caption

toggle caption
janiecbros/Getty Images

Neuroscience Has A Whiteness Problem. This Research Project Aims To Fix It

  • Download
  • <iframe src="https://www.npr.org/player/embed/915783973/916625460" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Researchers in Miami hold syringes containing either a placebo or the candidate COVID-19 vaccine from Moderna. Their work is part of a phase three clinical trial sponsored by the National Institutes of Health. Taimy Alvarez/AP hide caption

toggle caption
Taimy Alvarez/AP
Shots - Health News

Shots

Health News From NPR

About